Last reviewed · How we verify

NCT06613191: CAPTT

Colonoscopy and Antiplatelet Therapy Trial

Not yet recruiting Phase 4 Last updated 25 September 2024
What this trial tests

Phase 4 trial testing Aspirin in Coronary Arterial Disease (CAD) in 100 participants. Not yet recruiting.

Timeline
1 October 2024
Primary endpoint
31 December 2025
30 June 2026

Quick facts

Lead sponsorOchsner Health System
PhasePhase 4
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment100
Start date1 October 2024
Primary completion31 December 2025
Estimated completion30 June 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Ochsner Health System — full company profile →

Who can join

45 and older, any sex, with Coronary Arterial Disease (CAD) or Peripheral Vascular Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients on dual antiplatelet therapy )aspirin plus a P2Y12 inhibitor \[clopidogrel, prasugrel, or ticagrelor\]) undergoing screening or surveilance colonoscopy are at increased risk for bleeding from the procedure. Patients are ussually asked to stop the P2Y12 inhibitor for the procedure. Currently, recommendation is that patients only on a P2Y12 inhibitor be changes to aspirin for the procedure. This pilot study will evaluate if there is a large difference in bleeding between patients only taking aspirin compared with patients only taking a P2Y12 inhibitor. Patinets who participate will randomly be randomly asked to stop either aspirin or the P2Y12 inhibitor 1 week before the procedure. Periprocedural bleeding and bleeding after the procedure for iup to 30 days.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Aspirin

Trials testing the same drug.

Other recruiting trials for Coronary Arterial Disease (CAD)

Currently open trials in the same condition.

Other Ochsner Health System trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06613191.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing